Rubicon Financial Statements From 2010 to 2026
| ROMJF Stock | USD 0.35 0.01 2.78% |
Check Rubicon Organics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rubicon Organics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Rubicon financial statements analysis is a perfect complement when working with Rubicon Organics Valuation or Volatility modules.
Rubicon |
Rubicon Organics OTC Stock Return On Equity Analysis
Rubicon Organics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Rubicon Organics Return On Equity | -0.0569 |
Most of Rubicon Organics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rubicon Organics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Rubicon Organics has a Return On Equity of -0.0569. This is 99.76% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 81.65% lower than that of the firm.
Rubicon Organics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rubicon Organics's current stock value. Our valuation model uses many indicators to compare Rubicon Organics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rubicon Organics competition to find correlations between indicators driving Rubicon Organics's intrinsic value. More Info.Rubicon Organics is currently regarded as top stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rubicon Organics' earnings, one of the primary drivers of an investment's value.About Rubicon Organics Financial Statements
Rubicon Organics stakeholders use historical fundamental indicators, such as Rubicon Organics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Rubicon Organics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rubicon Organics' assets and liabilities are reflected in the revenues and expenses on Rubicon Organics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rubicon Organics. Please read more on our technical analysis and fundamental analysis pages.
Rubicon Organics Inc. produces and sells organic cannabis for the recreational and medical-use markets in Canada. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Rubicon Organics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 141 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Rubicon OTC Stock
Rubicon Organics financial ratios help investors to determine whether Rubicon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rubicon with respect to the benefits of owning Rubicon Organics security.